Fortrea Holdings (FTRE) Divestments (2024 - 2025)
Fortrea Holdings' (FTRE) quarterly Divestments came in at $20.6 million in Q3 2025, up 339.53% YoY from $4.7 million in Q3 2024, and up 8.42% on a QoQ basis from $19.0 million in Q1 2025.
Fortrea Holdings (FTRE) Divestments (2024 - 2025) Analysis & Trends
Fortrea Holdings (FTRE) has 2 years of Divestments data on file, last reported at $20.6 million in Q3 2025.
- Quarterly Divestments rose 339.53% year-over-year to $20.6 million in Q3 2025, while the trailing twelve-month figure through Jun 2026 was $20.6 million (up 98.08% YoY) and the FY2025 annual result came in at $39.6 million, down 85.68% from the prior year.
- Divestments climbed to $20.6 million in Q3 2025, from $19.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $285.2 million in Q2 2024 to a low of -$8.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 20.60 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Sep 30, 2024 | -8.60 Mn |
| Jun 30, 2024 | 285.20 Mn |